183 related articles for article (PubMed ID: 26574628)
1. Time trends in breast cancer and menopause hormone therapy use in New Zealand.
Farmer R; Fenton A
Climacteric; 2016; 19(1):42-8. PubMed ID: 26574628
[TBL] [Abstract][Full Text] [Related]
2. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
Simon JA; Nahum GG; Stanislaw H; Gaines T
Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer incidence and hormone replacement therapy in Canada.
De P; Neutel CI; Olivotto I; Morrison H
J Natl Cancer Inst; 2010 Oct; 102(19):1489-95. PubMed ID: 20864685
[TBL] [Abstract][Full Text] [Related]
4. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
Huang WF; Tsai YW; Hsiao FY; Liu WC
BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy and breast cancer risk 10 years after the WHI.
Gompel A; Santen RJ
Climacteric; 2012 Jun; 15(3):241-9. PubMed ID: 22612610
[TBL] [Abstract][Full Text] [Related]
6. Risks of hormone therapy in the 50-59 year age group.
van de Weijer PH
Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.
Crawford SL; Crandall CJ; Derby CA; El Khoudary SR; Waetjen LE; Fischer M; Joffe H
Menopause; 2018 Dec; 26(6):588-597. PubMed ID: 30586004
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
9. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?
Hofvind S; Sakshaug S; Ursin G; Graff-Iversen S
Int J Cancer; 2012 Jun; 130(12):2930-8. PubMed ID: 21732346
[TBL] [Abstract][Full Text] [Related]
11. Update in hormone therapy use in menopause.
Taylor HS; Manson JE
J Clin Endocrinol Metab; 2011 Feb; 96(2):255-64. PubMed ID: 21296989
[TBL] [Abstract][Full Text] [Related]
12. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination.
Wegienka G; Havstad S; Kelsey JL
J Womens Health (Larchmt); 2006 May; 15(4):369-78. PubMed ID: 16724885
[TBL] [Abstract][Full Text] [Related]
14. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
15. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
16. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
[TBL] [Abstract][Full Text] [Related]
17. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
18. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
Barber CA; Margolis K; Luepker RV; Arnett DK
J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
[TBL] [Abstract][Full Text] [Related]
19. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.
Watson J; Wise L; Green J
Eur J Clin Pharmacol; 2007 Sep; 63(9):843-9. PubMed ID: 17598097
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy use in 17 European countries during the last decade.
Ameye L; Antoine C; Paesmans M; de Azambuja E; Rozenberg S
Maturitas; 2014 Nov; 79(3):287-91. PubMed ID: 25156453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
